Funding for vaccine development
08 April 2020
Modified: 08 April 2020
Reading time: 1 minute(s)
On 16 March, the European Commission offered up to €80 million of financial support to CureVac, a highly innovative vaccine developer from Tübingen, Germany, to scale up development and production of a vaccine against the Coronavirus in Europe.
On 16 March, the European Commission offered up to €80 million of financial support to CureVac, a highly innovative vaccine developer from Tübingen, Germany, to scale up development and production of a vaccine against the Coronavirus in Europe. CureVac was previously the recipient of the EU's first inducement prize in 2014 for its innovative vaccine technology.
More information: https://ec.europa.eu/
Updated: 08 April 2020